36 min listen
Davor Hebel, Managing Partner at Eight Roads on the European entrepreneurial renaissance | E294
FromEUVC
Davor Hebel, Managing Partner at Eight Roads on the European entrepreneurial renaissance | E294
FromEUVC
ratings:
Length:
46 minutes
Released:
Apr 2, 2024
Format:
Podcast episode
Description
Today, we have Davor Hebel with us. Davor is the Managing Partner at Eight Roads, a $11bn global venture platform. The firm has over 450 portfolio companies, including 60 IPOs and many unicorns, such as Alibaba, Toast, Flywire, Chewy, Hibob, Neo4j, and Fever. Eight Roads invests in companies at scale-up stages (usually rounds A-C) and helps them win globally.Davor runs the Europe and Israel franchise with around 45 companies and $1.5bn AUM. Davor’s investments count leaders across SaaS, consumer, digital health, and fintech sectors, including Hibob, Appsflyer, Fever, Fireblocks, Owkin, Wallapop, ScyllaDB, Red Points, Packlink (sold to Auctane), Rimilia (Blackline), Innogames (MTG), and Treatwell (Recruit).Davor was born in Croatia and studied in the US. Davor is also passionate about sports, and he still tries to find time for some rowing, tennis, and Barry’s Bootcamp ? whilst raising his 3 kids (11, 9, and 6).Go to eu.vc for our core learnings and the full video interview ?Chapters:01:03 Davor's Journey: From in Venture Capital03:50 The Role of a VC: Beyond Investment04:12 Empathy and Support: The VC Approach to Entrepreneurship06:05 Balancing Business and Personal Life in Entrepreneurship06:53 The Evolution of a Founder's Role11:22 The Future of Technology: AI's Impact14:42 AI in Venture Capital: A Tool for Success17:00 The European Entrepreneurial Landscape: From Ice Age to Innovation19:45 The Growth and Potential of European Startups22:27 US Investor Participation in Europe24:06 Navigating the VC Landscape in a Changing Europe30:20 Davor's Top Learnings from a Decade in Venture Capital
Released:
Apr 2, 2024
Format:
Podcast episode
Titles in the series (100)
#1 Marc Lohrmann, Vesalius Biocapital: Episode 1 features Marc Lohrmann, Managing Partner of Vesalius Biocapital III, a 120 €M venture capital fund investing in late-stage companies in drug development, medical devices & diagnostics and eHealth / mHealth, across all of Europe. Prior to... by EUVC